- Home
- AORT vs KBDC Comparison
AORT vs KBDC Comparison
Compare AORT & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- KBDC
- Stock Information
- Founded
- AORT 1984
- KBDC 2021
- Country
- AORT United States
- KBDC United States
- Employees
- AORT N/A
- KBDC N/A
- Industry
- AORT Medical/Dental Instruments
- KBDC
- Sector
- AORT Health Care
- KBDC
- Exchange
- AORT Nasdaq
- KBDC Nasdaq
- Market Cap
- AORT 1.4B
- KBDC 1.1B
- IPO Year
- AORT 1993
- KBDC N/A
- Fundamental
- Price
- AORT $31.66
- KBDC $16.07
- Analyst Decision
- AORT Strong Buy
- KBDC Buy
- Analyst Count
- AORT 5
- KBDC 4
- Target Price
- AORT $32.40
- KBDC $16.38
- AVG Volume (30 Days)
- AORT 357.6K
- KBDC 140.8K
- Earning Date
- AORT 08-07-2025
- KBDC 08-11-2025
- Dividend Yield
- AORT N/A
- KBDC 11.79%
- EPS Growth
- AORT N/A
- KBDC N/A
- EPS
- AORT N/A
- KBDC N/A
- Revenue
- AORT $390,084,000.00
- KBDC N/A
- Revenue This Year
- AORT $12.18
- KBDC $193.84
- Revenue Next Year
- AORT $10.39
- KBDC $12.68
- P/E Ratio
- AORT N/A
- KBDC N/A
- Revenue Growth
- AORT 5.94
- KBDC N/A
- 52 Week Low
- AORT $21.97
- KBDC $13.93
- 52 Week High
- AORT $32.94
- KBDC $17.99
- Technical
- Relative Strength Index (RSI)
- AORT 62.03
- KBDC N/A
- Support Level
- AORT $30.06
- KBDC N/A
- Resistance Level
- AORT $32.94
- KBDC N/A
- Average True Range (ATR)
- AORT 0.79
- KBDC 0.00
- MACD
- AORT 0.06
- KBDC 0.00
- Stochastic Oscillator
- AORT 61.37
- KBDC 0.00
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.